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Editorial
COVID-19 and the global OHCA crisis: An urgent need
for system level solutions
In this edition of Resuscitation, two systematic reviews1,2 and a
national Spanish cohort study3 highlight the alarming impact of the
COVID-19 pandemic on the management and outcomes of out-of-
hospital cardiac arrest (OHCA). The rapidly increasing literature in this
area is highlighted by the difference in the number of identified studies
between the two systematic reviews, despite only a small difference in
search dates. Compared with historical data, these papers consis-
tently show that during the COVID-19 period there were more cardiac
arrests in the home, ambulance response time increased, and a
marked decrease in patient survival. In contrast to data included in the
two systematic reviews, OHCA incidence in Spain actually decreased
although this is likely explained by differences in system response.
The net result is a significant excess OHCA mortality during the
COVID-19 period.
Studies to date provide important information as to what has
happened during the peak of COVID-19, and should drive others to
explore changes in their own system. The findings do, however, raise
three critical questions for clinicians, public health and policy makers:
1) Which factors drive the increase in OHCA incidence and mortality
during pandemic periods?
2) What actions are needed to limit the medium- and long-term
impact of COVID-19 on OHCA, particularly as cases fall and
lockdown measures decrease?
3) What actions are needed to limit the impact on OHCA in future
waves of the COVID-19 pandemic or future pandemics?
COVID-19 has directly impacted on each link in the cardiac arrest
chain of survival.4 However, the mechanisms that have led to this
impact reflect the direct effects of COVID-19, the indirect effects of
COVID-19 and the wider societal context.5 In the context of OHCA,
these causal pathways are inevitably complex and our understanding
is very limited. In Fig. 1, we present broader system factors that may
influence these causal pathways. Improving our understanding of
these factors will require our OHCA data collection to move beyond the
standard Utstein dataset.6 In the remainder of this editorial, we
highlight some of the key data needed to help us better understand
these causal pathways.
The direct contribution of COVID-19 infections on excess OHCA
incidence and mortality is uncertain. Studies to date suggest less than
one-third of this excess can be explained by individuals with known or
presumed COVID-19 infection.7,8 However, these data likely under-
report the true effect due to narrow Public Health case definitions,
compared with the diverse symptoms with which patients commonly
present.9 Comprehensive laboratory testing of patients for SARS-
CoV, in particular those where resuscitation efforts are either not
initiated or terminated in the field, would support our understanding of
the extent of the direct effect of COVID-19 on OHCA. In view of the
challenges associated with any additional burden on COVID-19
testing capability and potential issues associated with false-neg-
atives, indirect epidemiological evidence that explores whether OHCA
incidence and mortality is associated with factors such as COVID-19
case numbers and system changes (e.g. lockdowns) would also be
informative.
In patients infected with COVID-19, improved understanding of
OHCA pathophysiology may inform potential mitigations and the
clinical management of OHCA. In some patients, the OHCA may be
precipitated by hypoxic respiratory failure.9 This might also explain, in
part, the lower rate of shockable rhythms documented in the pandemic
OHCA cohorts1,2 and may also have implications regarding the utility
of providing ‘hands only’ bystander CPR in these patients.
Additionally, SARS-CoV infection has also been documented to
cause myocarditis,10 arrythmias,11 and a hyper-coagulable state
leading to thrombotic events including cerebral vascular acci-
dents.12,13 The degree to which these factors may be causing OHCA
can only be determined by conducting and reporting post-mortem
findings on these patients as well as collecting and analysing data on
patient’s symptoms and clinical course prior to their cardiac arrest. To
date, there have been few studies of post-mortems on COVID-19
patients and none specifically on OHCA patients.14 Similarly, several
of the studies on OCHA during COVID-19 reported as limitations the
lack of availability of clinical data beyond the standard Utstein
template.6
Across many healthcare systems, health and social care services
were reconfigured in response to the pandemic. These changes
included reducing access to preventive care across both primary and
secondary care, and cancellation of elective operations. In addition,
clinical pathways were redesigned to support telemedicine and limit
face-to-face direct contact between healthcare providers and
patients, except where deemed essential.15,16 Guidelines were also
changed for dispatchers and responders regarding ambulance
dispatch and patient transport decisions. Prior to COVID-19, there
was increasing evidence that OHCA patients often accessed
healthcare services in the period preceding their cardiac arrest.17
19 In view of the uncertain impact of healthcare system changes
in response to COVID-19 and potential risks of under-triage or over-
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triage when assessing patients over the telephone, there is a need to
understand how frequently OHCA patients contacted the health care
system prior to their arrest, the associated clinical advice, and the
extent to whether this advice was impacted by changes in response to
COVID-19.
Clinical concern regarding the risk of transmission of COVID-19
infection risk to the bystander drove modifications to changes in
cardiac arrest clinical guidelines and the personal protective
equipment (PPE) worn by pre-hospital responders and dispatch-
ers.2022 The requirement to wear this PPE was identified as leading
to potential delays in both the dispatch process as well as the medical
response.2 This concern may also have contributed to reduced
incidence of bystander CPR.23 While important to protect clinicians
from the additional risk potentially associated with treating an
infectious patient in cardiac arrest,24 much uncertainty remains
regarding the specific risk associated with various treatments and
interventions delivered during a resuscitation25 and in particular the
most appropriate mitigation strategies for use in the pre-hospital
setting. Further research is warranted to inform the requirements and
design of PPE for use in the pre-hospital setting.
Understanding the causal factors associated with the excess
OHCA incidence and mortality during the pandemic will inform
strategies to limit the effect of future pandemic waves. Internationally,
we have tended to focus on the obvious cases of COVID-19
presenting to hospitals, often in overwhelming numbers. Stepping
back to take a broader system view will ensure that we do not miss
other potential opportunities to save lives. The consistent evidence
across multiple healthcare systems in relation to OHCA is a red flag,
that highlights the need for a coordinated response.
Many countries are now entering a second wave of COVID-19. We
must use this opportunity to move away from siloed care delivery to
ensure a co-ordinated system-wide (pre-hospital care, hospital care,





R E F E R E N C E S
1. Lim, et al. Incidence and outcome of out-of-hospital cardiac arrests in
the COVID-19 era: a systematic review and meta-analysis.
Resuscitation 2020;157:24858.
2. Scquizzato, et al. Effects of COVID-19 pandemic on out-of-hospital
cardiac arrests: a systematic review. Resuscitation 2020;157:2417.
3. Ortiz, et al. Influence of the Covid-19 pandemic on out-of-hospital
cardiac arrest. A Spanish nationwide prospective cohort study.
Resuscitation 2020;157:23040.
4. Nolan J, Soar J, Eikeland H. The chain of survival. Resuscitation
2006;71:2701.
5. Gupta R, Dhamija RK. Covid-19: social distancing or social isolation?
BMJ 2020;369.
6. Perkins GD, Jacobs IG, Nadkarni VM, et al. Cardiac arrest and
cardiopulmonary resuscitation outcome reports: update of the utstein
resuscitation registry templates for out-of-hospital cardiac arrest.
Resuscitation 2015;32840.
7. Marijon E, Karam N, Jost D, et al. Out-of-hospital cardiac arrest during
the COVID-19 pandemic in Paris, France: a population-based,
observational study. Lancet Public Health 2020;5(8):e43743.
8. Sayre MR, Barnard LM, Counts CR, et al. Prevalence of COVID-19 in
out-of-hospital cardiac arrest: implications for bystander CPR.
Circulation 2020;142:5079, doi:http://dx.doi.org/10.1161/
CIRCULATIONAHA.120.048951.
9. Pritchard M, Dankwa EA, Hall M, et al. ISARIC clinical data report 4
October 2020. medRxiv 2020, doi:http://dx.doi.org/10.1101/
2020.07.17.20155218.
10. Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-
related myocarditis: the possible pathophysiology and proposed
guideline for diagnosis and management. Heart Rhythm 2020, doi:
http://dx.doi.org/10.1016/j.hrthm.2020.05.001.
11. Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac
arrhythmias. Heart Rhythm 2020;17:143944.
12. Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting
feature of Covid-19 in the young. N Engl J Med 2020;382:e60.
Fig. 1 – Systems level factors related to OHCA incidence and mortality during the COVID-19 pandemic.
R E S U S C I T A T I O N 1 5 7 ( 2 0 2 0 ) 2 7 4 2 7 6 275
13. Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke.
Transl Stroke Res 2020;1.
14. Maiese A, Manetti AC, La Russa R, et al. Autopsy findings in COVID-
19-related deaths: a literature review. Forensic Sci Med Pathol 2020;1
18.
15. Avery J, Bloom B. COVID-19, a UK perspective. Eur J Emerg Med
2020;27(3):1567, doi:http://dx.doi.org/10.1097/
MEJ.0000000000000700.
16. Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19.
N Engl J Med 2020;382:167981.
17. Shuvy M, Koh M, Qiu F, et al. Health care utilization prior to out-of-
hospital cardiac arrest: a population-based study. Resuscitation
2019;141:15865.
18. Lee SY, Song KJ, Do Shin S, Hong KJ. Epidemiology and outcome of
emergency medical service witnessed out-of-hospital-cardiac arrest
by prodromal symptom: nationwide observational study.
Resuscitation 2020;150:509.
19. Marijon E, Uy-Evanado A, Dumas F, et al. Warning symptoms are
associated with survival from sudden cardiac arrest. Ann Internal Med
2016;164:239.
20. Leong YC, Cheskes S, Drennan IR, Buick JE, Latchmansingh RG,
Verbeek PR. Clinical considerations for out-of-hospital cardiac arrest
management during COVID-19. Resuscitation Plus 2020;4:100027.
21. Jost D, Derkenne C, Kedzierewicz R, et al. The need to adapt the
rescue chain for out-of-hospital cardiac arrest during the COVID-19
pandemic: experience from the Paris fire brigade basic life support and
advanced life support teams. Resuscitation 2020;153:567.
22. Perkins G, Morley P, Nolan J, et al. International liaison committee on
resuscitation: COVID-19 consensus on science, treatment
recommendations and task force insights. Resuscitation 2020;
151:1457.
23. Grunau B, Bal J, Scheuermeyer F, et al. Bystanders are less willing to
resuscitate out-of-hospital cardiac arrest victims during the COVID-19
pandemic. Resuscitation Plus 2020;100034.
24. Christian MD, Loutfy M, McDonald LC, et al. Possible SARS
coronavirus transmission during cardiopulmonary resuscitation.
Emerg Infect Dis 2004;10:287.
25. Couper K, Taylor-Phillips S, Grove A, et al. COVID-19 in cardiac arrest
and infection risk to rescuers: a systematic review. Resuscitation
2020;151:5966.
Michael D. Christian*
London’s Air Ambulance, Royal London Hospital, Barts NHS Health
Trust, UK
Keith Coupera,b
aWarwick Medical School, University of Warwick, Coventry, UK
bCritical Care Unit, University Hospitals Birmingham NHS Foundation
Trust, Birmingham, UK
* Corresponding author at: Royal London Hospital Helipad,
Whitechapel Rd, Whitechapel, London E1 1FR, England, UK.
E-mail address: Michael.christian@utoronto.ca (M. Christian).
http://dx.doi.org/10.1016/j.resuscitation.2020.11.004
Crown Copyright © 2020 Published by Elsevier B.V. All rights
reserved.
276 R E S U S C I T A T I O N 1 5 7 ( 2 0 2 0 ) 2 7 4 2 7 6
